Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 9, 2012, Pages 1449-1461

  Rbah Vidal, Latifa ^a,b   Vidal, Aurélien ^a,b   Besse, Sophie ^a,b   Cachin, Florent ^a,b,c   Bonnet, Mathilde ^a   Audin, Laurent ^a,b   Askienazy, Serge ^d   Dollé, Frédéric ^e   Degoul, Françoise ^a,b   Miot Noirault, Elisabeth ^a,b   Moins, Nicole ^a,b   Auzeloux, Philippe ^a,b   Chezal, Jean Michel ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b INSERM   (France)

^c CENTRE JEAN PERRIN   (France)

^d Academisch Centrum Kinder en Jeugdpsychiatrie Curium   (France)

^e SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

18F; 18F ICF01006; Melanin; Melanoma imaging; Metastsis; Small animal PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; N [2 (DIETHYLAMINO)ETHYL] 6 FLUOROPYRIDINE 3 CARBOXAMIDE F 18; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISSEMINATED CANCER; EARLY DIAGNOSIS; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SUBSTITUTION REACTION; SYNTHESIS; TUMOR GROWTH;

ANIMALS; BIOLOGICAL TRANSPORT; EARLY DETECTION OF CANCER; LONGITUDINAL STUDIES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NIACINAMIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RADIOCHEMISTRY;

EID: 84865619393     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2168-y     Document Type: Article

References (28)

1. P Lorigan T Eisen A Hauschild 2008 Systemic therapy for metastatic malignant melanoma-from deeply disappointing to bright future? Exp Dermatol 17 383 394 18312390 10.1111/j.1600-0625.2007.00673.x 1:CAS:528:DC%2BD1cXmslKlt70%3D
2. JF Thompson RA Scolyer RF Kefford 2005 Cutaneous melanoma Lancet 365 687 701 15721476 1:CAS:528:DC%2BD2MXhsVOitLc%3D
3. C Garbe U Leiter 2009 Melanoma epidemiology and trends Clin Dermatol 27 3 9 19095149 10.1016/j.clindermatol.2008.09.001
4. L Jennings GM Murphy 2009 Predicting outcome in melanoma: where are we now? Br J Dermatol 161 496 503 19624540 10.1111/j.1365-2133.2009.09324.x 1:CAS:528:DC%2BD1MXht1WnsL7M
5. E de Vries FI Bray JW Coebergh DM Parkin 2003 Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and deceases in Scandinavia Int J Cancer 107 119 126 12925966 10.1002/ijc.11360
6. C Garbe TK Eigentler U Keilholz A Hauschild JM Kirkwood 2011 Systematic review of medical treatment in melanoma: current status and future prospects Oncologist 16 5 24 21212434 10.1634/theoncologist.2010-0190 1:CAS:528: DC%2BC3MXisV2qtLw%3D
7. Y Xing Y Bronstein MI Ross RL Askew JE Lee JE Gershenwald, et al. 2011 Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis J Natl Cancer Inst 103 129 142 21081714 10.1093/jnci/djq455
8. JD Wagner 2004 A role for FDG-PET in the surgical management of stage IV melanoma Ann Surg Oncol 11 721 722 15249339 10.1245/ASO.2004.06.923
9. F Jiménez-Requena RC Delgado-Bolton C Fernández- Pérez SS Gambhir J Schwimmer JM Pérez-Vásquez, et al. 2010 Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma Eur J Nucl Med Mol Imaging 37 284 300 19727717 10.1007/s00259-009-1224-8
10. G Ren S Liu H Liu Z Miao Z Cheng 2010 Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1 Bioconjug Chem 21 2355 2360 21073170 10.1021/bc100391a 1:CAS:528:DC%2BC3cXhsVWhsbfJ
11. MV Cantorias SD Figueroa TP Quinn JR Lever TJ Hoffman LD Watkinson, et al. 2009 Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized α-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors Nucl Med Biol 36 505 513 19520291 10.1016/j.nucmedbio.2009.01.017 1:CAS:528:DC%2BD1MXnt1Gqt74%3D
12. G Ren Z Liu Z Miao H Liu M Subbarayan FT Chin, et al. 2009 PET of malignant melanoma using 18F-labeled metallopeptides J Nucl Med 50 1865 1872 19837749 10.2967/jnumed.109.062877 1:CAS:528:DC%2BD1MXhsVyqs7rO
13. Z Cheng Z Xiong M Subbarayan X Chen SS Gambhir 2007 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression Bioconjug Chem 18 765 772 17348700 10.1021/bc060306g 1:CAS:528:DC%2BD2sXis1Ghs7o%3D
14. SE Koch JR Lange 2000 Amelanotic melanoma: the great masquerader J Am Acad Dermatol 42 731 734 10775846 10.1067/mjd.2000.103981 1:STN:280: DC%2BD3c3jvF2kuw%3D%3D
15. Moreau MF, Michelot J, Veyre A, Madelmont JC, Godeneche D, Labarre P, et al. Agents for diagnosing and treating melanomas, aromatic halogenated derivative usable as such agents and their preparation. Patent WO/1990/009170.
16. Chezal JM, Madelmont JC, Teulade JC, Chavignon O, Moins N. Labelled analogues of halobenzamides as radiopharmaceuticals. Patent WO/2008/12782.
17. JM Michelot MF Moreau AJ Veyre JF Bonafous FJ Bacin JC Madelmont, et al. 1993 Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide) J Nucl Med 34 1260 1266 8326382 1:STN:280:DyaK3szhs1Wlsg%3D%3D
18. A Maisonial B Kuhnast J Papon R Boisgard M Bayle A Vidal, et al. 2011 Single photon emission computed tomography/positron emission tomography imaging and targeted radionuclide therapy of melanoma: new multimodal fluorinated and iodinated radiotracers J Med Chem 54 2745 2766 21417462 10.1021/jm101574q 1:CAS:528:DC%2BC3MXjsFKmsbo%3D
19. N Moins M D'Incan J Bounafous F Bacin P Labarre MF Moreau, et al. 2002 123I-N-(2-diethylaminoethyl)-2-iodobenzamide : a potential agent for cutaneous melanoma staging Eur J Nucl Med Mol Imaging 29 1478 1484 12397467 10.1007/s00259-002-0971-6 1:CAS:528:DC%2BD38XotV2itr0%3D
20. S Garg K Khotari SR Thopate AK Doke PK Garg 2009 Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F] fluorobenzamide ([18F]DAFBA): a novel potential PET probe to image melanoma tumors Bioconjug Chem 20 583 590 19222206 10.1021/bc8005094 1:CAS:528: DC%2BD1MXhvFGmsbw%3D
21. G Ren Z Miao H Liu L Jiang N Limpa-Amara A Mahmood, et al. 2009 Melanin-targeted preclinical PET imaging of melanoma metastasis J Nucl Med 50 1692 1699 19759116 10.2967/jnumed.109.066175 1:CAS:528:DC%2BD1MXhtlehsbnO
22. I Greguric SR Taylor D Denoyer P Ballantyne P Berghofer P Roselt, et al. 2009 Discovery of [18F]N-(2-(diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance J Med Chem 52 5299 5302 19691348 10.1021/jm9008423 1:CAS:528:DC%2BD1MXhtVWntbfP
23. D Denoyer I Greguric P Roselt OC Neels N Aide SR Taylor, et al. 2010 High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance J Nucl Med 51 441 447 20150254 10.2967/jnumed.109.070060 1:CAS:528:DC%2BC3cXksVylsr0%3D
24. BH Mock W Winkle MT Vavrek 1997 A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations Nucl Med Biol 24 193 195 9089712 10.1016/S0969-8051(96)00212-0 1:CAS:528:DyaK2sXitlOmu7k%3D
25. Y Wang J Seidel BMW Tsui JJ Vaquero MG Pomper 2006 Performance evaluation of GE healthcare eXplore VISTA dual-ring small-animal PET scanner J Nucl Med 47 1891 1900 17079824
26. T Yamamoto Y Seino H Fukumoto G Koh H Yano N Inagaki, et al. 1990 Over-expression of facilitative glucose transporter genes in human cancer Biochem Biophys Res Commun 170 223 230 2372287 10.1016/0006-291X(90)91263-R 1:CAS:528:DyaK3cXltFeisLk%3D
27. P Labarre J Papon MF Moreau N Moins M Bayle A Veyre, et al. 2002 Melanin affinity of N-(2-diethylaminoethyl)-4-iodobenzamide, an effective melanoma imaging agent Melanoma Res 12 115 121 11930107 10.1097/00008390-200204000-00003 1:CAS:528:DC%2BD38XjslCru7k%3D
28. P Labarre J Papon AH Rose JL Guerquin-Kern L Morandeau TD Wu, et al. 2008 Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4- dipropylaminobutyl)-4-iodobenzamide, a new targeting agent Nucl Med Biol 35 783 791 18848663 10.1016/j.nucmedbio.2008.07.003 1:CAS:528:DC%2BD1cXht1egtb7P